What is Beijing Foyou Pharma CO.,LTD's (601089.SS) StockRank?

MoatMap's StockRank for Beijing Foyou Pharma CO.,LTD (601089.SS) is 61/100, with a Hold signal. This is a composite score combining Quality (73), Value (52), and Momentum (25) factor ranks across MoatMap's 19,000+ stock universe.

Does Beijing Foyou Pharma CO.,LTD have an economic moat?

Beijing Foyou Pharma CO.,LTD (601089.SS) has a Quality factor score of 73/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Beijing Foyou Pharma CO.,LTD a buy, hold, or sell?

MoatMap's current signal for Beijing Foyou Pharma CO.,LTD (601089.SS) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Beijing Foyou Pharma CO.,LTD in?

Beijing Foyou Pharma CO.,LTD (601089.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

601089.SS

HOLDREMOVE

Beijing Foyou Pharma CO.,LTD · Healthcare · China · $1.3B · Avg Vol: $7M/d

StockRank

P/E (TTM)

17.6x

ROE

11.5%

D/E

0.0x

Dividend %

3.0%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Beijing Foyou Pharma is a domestic Chinese pharmaceutical company. While it exhibits a solid quality score (Q: 73), it operates primarily as a traditional drug developer rather than a high-moat, global CDMO beneficiary, failing to align with our specific CDMO pricing power theme.

COMPANY DESCRIPTION

Beijing Foyou Pharma Co., Ltd. specializes in the research, development, manufacture, and sale of chemical active pharmaceutical ingredients (APIs) and finished generic drug formulations. The company focuses on therapeutic areas such as cardiovascular diseases, anti-infectives, and endocrine disorders. Its competitive moat lies in its high-quality API self-sufficiency, GMP-compliant manufacturing facilities, and strong penetration in China's centralized procurement system.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	479M	494M	509M	518M	2.6%
EPS	0.15	0.15	0.15	0.15	-1.3%
Shares	480M	480M	480M	480M	0.0%
Debt	18M	18M	11M	4M	-40.6%
Equity	469M	513M	524M	559M	6.0%
Op CF	98M	82M	102M	53M	-18.2%
Inv CF	-5M	-57M	-298M	-22M	—
Fin CF	221M	-31M	-69M	-43M	—

PRICE (1M)-21.5%

SMA 50SMA 200

$2.42

RSI (14)

20.3

52W High

$4.82

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

13.6%82.0

ROE

11.5%75.6

GP/Assets

45.4%83.3

Op. Margin

12.4%70.5

FCF/Assets

-0.9%47.1

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.01x92.5

Current Ratio

3.18x55.6

Value

P/E (TTM)

17.6x65.0

EV/EBITDA

9.8x42.8

P/FCF

—N/A

P/B

2.0x55.8

P/S

2.3x64.5

Div Yield

3.0%70.7

Momentum

52W High %

50%23.9

RS 6M

-40%29.6

SMA 50/200

0.87x24.6

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

-27%19.6

FUNDAMENTALS

Market Cap

$1.3B

P/E (Forward)

—

Gross Margin

63.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 601089.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
601089.SS	Beijing Foyou Pharma CO.,LTD(you)	$1.3B	61	HOLD
000756.SZ	Shandong Xinhua Pharmaceutical Company Limited	$1.4B	62	HOLD
300725.SZ	PharmaBlock Sciences (Nanjing), Inc.	$1.2B	60	HOLD
2186.HK	Luye Pharma Group Ltd.	$1.1B	61	HOLD
603456.SS	Zhejiang Jiuzhou Pharmaceutical Co., Ltd	$1.7B	62	HOLD
002550.SZ	Changzhou Qianhong Biopharma CO.,LTD	$1.2B	66	BUY
600557.SS	Jiangsu Kanion Pharmaceutical Co.,Ltd.	$1.1B	65	HOLD
600195.SS	China Animal Husbandry Industry Co., Ltd.	$996M	64	HOLD
000597.SZ	Northeast Pharmaceutical Group Co., Ltd.	$983M	64	HOLD
300119.SZ	Tianjin Ringpu Bio-Technology Co.,Ltd.	$1.1B	55	HOLD

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Beijing Foyou Pharma CO.,LTD (601089.SS) — Stock Score Summary

Beijing Foyou Pharma CO.,LTD (601089.SS) has a MoatMap StockRank of 61/100 based on Quality (73/100), Value (52/100), and Momentum (25/100) factor scores. The current signal is HOLD. Beijing Foyou Pharma is a domestic Chinese pharmaceutical company. While it exhibits a solid quality score (Q: 73), it operates primarily as a traditional drug developer rather than a high-moat, global CDMO beneficiary, failing to align with our specific CDMO pricing power theme.

Key Financial Metrics

Price	$2.42
Market Cap	$1.3B
P/E (TTM)	17.62
Price/Book	1.98
Return on Equity	11.5%
Return on Invested Capital	13.6%
Debt/Equity	0.51
Gross Margin	63.9%
Operating Margin	12.4%
Revenue Growth	-2.3%
Dividend Yield	3.0%
Free Cash Flow	$-958K

Beijing Foyou Pharma CO.,LTD operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Beijing Foyou Pharma CO.,LTD’s (601089.SS) StockRank?: MoatMap’s StockRank for Beijing Foyou Pharma CO.,LTD (601089.SS) is 61/100, with a Hold signal. It is a composite of Quality (73), Value (52), and Momentum (25) factor ranks across MoatMap’s 19,000+ stock universe.
Does Beijing Foyou Pharma CO.,LTD have an economic moat?: Beijing Foyou Pharma CO.,LTD (601089.SS) has a Quality factor score of 73/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Beijing Foyou Pharma CO.,LTD a buy, hold, or sell?: MoatMap’s current signal for Beijing Foyou Pharma CO.,LTD (601089.SS) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Beijing Foyou Pharma CO.,LTD in?: Beijing Foyou Pharma CO.,LTD (601089.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).